Medicure shares MEND-PNPO Phase 3 design and baseline data at congress
Medicure announced its MEND-PNPO Phase 3 study design and baseline data at the 16th European Epilepsy Congress.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Medicure announced its MEND-PNPO Phase 3 study design and baseline data at the 16th European Epilepsy Congress.